These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 12628368)

  • 21. Viral vectors: a wide range of choices and high levels of service.
    Osten P; Grinevich V; Cetin A
    Handb Exp Pharmacol; 2007; (178):177-202. PubMed ID: 17203656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential of oligonucleotides for therapeutic applications.
    Fichou Y; Férec C
    Trends Biotechnol; 2006 Dec; 24(12):563-70. PubMed ID: 17045686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection control for gene therapy: a busy physician's primer.
    Evans ME; Lesnaw JA
    Clin Infect Dis; 2002 Sep; 35(5):597-605. PubMed ID: 12173136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gene therapy: new developments].
    Mohr L; Geissler M
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
    Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
    Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral vectors for gene delivery in tissue engineering.
    Zhang X; Godbey WT
    Adv Drug Deliv Rev; 2006 Jul; 58(4):515-34. PubMed ID: 16762441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activators of viral gene expression in polarized epithelial monolayers identified by rapid-throughput drug screening.
    Sorscher EJ; Harris J; Alexander M; Rottgers A; Hardy K; Ponnazhagan S; Collawn JF; McClintock J; Amsler CD; Webster A; Maddry J; Baker BJ; Hong JS
    Gene Ther; 2006 May; 13(9):781-8. PubMed ID: 16307002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy for cystic fibrosis.
    Flotte TR
    Curr Opin Mol Ther; 1999 Aug; 1(4):510-6. PubMed ID: 11713767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy -- promises, problems and prospects.
    Verma IM; Somia N
    Nature; 1997 Sep; 389(6648):239-42. PubMed ID: 9305836
    [No Abstract]   [Full Text] [Related]  

  • 32. Cell-selective viral gene delivery vectors for the vasculature.
    Baker AH; Kritz A; Work LM; Nicklin SA
    Exp Physiol; 2005 Jan; 90(1):27-31. PubMed ID: 15542621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Library selection and directed evolution approaches to engineering targeted viral vectors.
    Jang JH; Lim KI; Schaffer DV
    Biotechnol Bioeng; 2007 Oct; 98(3):515-24. PubMed ID: 17614321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral vectors show promise in Colorado.
    Reynolds PN; Curiel DT
    Nat Biotechnol; 1998 May; 16(5):422-3. PubMed ID: 9592388
    [No Abstract]   [Full Text] [Related]  

  • 35. Viral vectors in gene therapy.
    Smith AE
    Annu Rev Microbiol; 1995; 49():807-38. PubMed ID: 8561480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy progress and prospects: adenoviral vectors.
    St George JA
    Gene Ther; 2003 Jul; 10(14):1135-41. PubMed ID: 12833122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of viral and nonviral vectors for gene transfer to human endothelial progenitor cells.
    Kealy B; Liew A; McMahon JM; Ritter T; O'Doherty A; Hoare M; Greiser U; Vaughan EE; Maenz M; O'Shea C; Barry F; O'Brien T
    Tissue Eng Part C Methods; 2009 Jun; 15(2):223-31. PubMed ID: 19196124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral vectors for gene transfer: current status of gene therapeutics.
    Heilbronn R; Weger S
    Handb Exp Pharmacol; 2010; (197):143-70. PubMed ID: 20217529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications.
    Romano G; Michell P; Pacilio C; Giordano A
    Stem Cells; 2000; 18(1):19-39. PubMed ID: 10661569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harmful potential of viral vectors fuels doubts over gene therapy.
    Check E
    Nature; 2003 Jun; 423(6940):573-4. PubMed ID: 12789298
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.